Disruption_NN
of_IN
the_DT
human_JJ
SCL_NN
locus_NN
by_IN
``_JJ
illegitimate_JJ
''_JJ
V_NN
-_:
-LRB-_-LRB-
D_NN
-RRB-_-RRB-
-_:
J_NN
recombinase_NN
activity_NN
._.

A_DT
fusion_NN
complementary_JJ
DNA_NN
in_IN
the_DT
T_NN
cell_NN
line_NN
HSB-2_NN
elucidates_VBZ
a_DT
provocative_JJ
mechanism_NN
for_IN
the_DT
disruption_NN
of_IN
the_DT
putative_JJ
hematopoietic_JJ
transcription_NN
factor_NN
SCL_NN
._.

The_DT
fusion_NN
cDNA_NN
results_VBZ
from_IN
an_DT
interstitial_JJ
deletion_NN
between_IN
a_DT
previously_RB
unknown_JJ
locus_NN
,_,
SIL_NN
-LRB-_-LRB-
SCL_NN
interrupting_NN
locus_NN
-RRB-_-RRB-
,_,
and_CC
the_DT
5_CD
'_``
untranslated_JJ
region_NN
of_IN
SCL_NN
._.

Similar_JJ
to_TO
1_CD
;_:
14_CD
translocations_NNS
,_,
this_DT
deletion_NN
disrupts_VBZ
the_DT
SCL_NN
5_CD
'_``
regulatory_JJ
region_NN
._.

This_DT
event_NN
is_VBZ
probably_RB
mediated_VBN
by_IN
V_NN
-_:
-LRB-_-LRB-
D_NN
-RRB-_-RRB-
-_CC
J_NN
recombinase_NN
activity_NN
,_,
although_IN
neither_DT
locus_NN
is_VBZ
an_DT
immunoglobulin_NN
or_CC
a_DT
T_NN
cell_NN
receptor_NN
._.

Two_CD
other_JJ
T_NN
cell_NN
lines_NNS
,_,
CEM_NN
and_CC
RPMI_NN
8402_CD
,_,
have_VBP
essentially_RB
identical_JJ
deletions_NNS
._.

Thus_RB
,_,
in_IN
lymphocytes_NNS
,_,
growth-affecting_JJ
genes_NNS
other_JJ
than_IN
immune_JJ
receptors_NNS
risk_VBP
rearrangements_NNS
._.

